Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data
- PMID: 28138913
- DOI: 10.1007/s12265-017-9730-8
Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data
Erratum in
-
Correction to: Usefulness of Genetic Testing in Hypertrophic Cardiomyopathy: an Analysis Using Real-World Data.J Cardiovasc Transl Res. 2019 Aug;12(4):389-390. doi: 10.1007/s12265-019-09901-5. J Cardiovasc Transl Res. 2019. PMID: 31309403
Abstract
This study sought to determine the usefulness of genetic testing to predict evolution in hypertrophic cardiomyopathy (HCM) and to assess the role of genetic testing in clinical practice. Genetic results of 100 HCM patients tested for mutations in ≥10 HCM-causing genes were evaluated. Patients were classified as with poor (group A) or favourable (group B) clinical course. Forty-five pathogenic mutations (PM) were identified in 28 patients (56 %) from group A and in 23 (46 %) from group B (p = 0.317). Only 40 patients (40 %) exhibited PM that had been previously reported and only 15 (15 %) had PM reported in ≥10 individuals. PM associated with poor prognosis were identified in just five patients from group A (10 %). Genetic findings are not useful to predict prognosis in most HCM patients. By contrast, real-world data reinforce the usefulness of genetic testing to provide genetic counselling and to enable cascade genetic screening.
Keywords: Family screening; Genetics; Hypertrophic cardiomyopathy; Mutations; Prognosis.
Similar articles
-
Evaluation of the Mayo Clinic Phenotype-Based Genotype Predictor Score in Patients with Clinically Diagnosed Hypertrophic Cardiomyopathy.J Cardiovasc Transl Res. 2016 Apr;9(2):153-61. doi: 10.1007/s12265-016-9681-5. Epub 2016 Feb 25. J Cardiovasc Transl Res. 2016. PMID: 26914223 Free PMC article.
-
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.J Am Coll Cardiol. 2012 Aug 21;60(8):705-15. doi: 10.1016/j.jacc.2012.02.068. Epub 2012 Jul 11. J Am Coll Cardiol. 2012. PMID: 22796258 Review.
-
Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy.Circ Genom Precis Med. 2018 Apr;11(4):e001896. doi: 10.1161/CIRCGEN.117.001896. Circ Genom Precis Med. 2018. PMID: 29661763
-
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.J Am Coll Cardiol. 2004 Aug 4;44(3):602-10. doi: 10.1016/j.jacc.2004.04.039. J Am Coll Cardiol. 2004. PMID: 15358028
-
A new era in clinical genetic testing for hypertrophic cardiomyopathy.J Cardiovasc Transl Res. 2009 Dec;2(4):381-91. doi: 10.1007/s12265-009-9139-0. Epub 2009 Oct 30. J Cardiovasc Transl Res. 2009. PMID: 20559996 Review.
Cited by
-
Genetic Testing in Inherited Heart Diseases: Practical Considerations for Clinicians.Curr Cardiol Rep. 2017 Aug 16;19(9):88. doi: 10.1007/s11886-017-0885-3. Curr Cardiol Rep. 2017. PMID: 28812208 Review.
-
The associations among genetic features, late gadolinium enhancement and prognosis in hypertrophic cardiomyopathy.Front Cardiovasc Med. 2025 Jul 7;12:1597405. doi: 10.3389/fcvm.2025.1597405. eCollection 2025. Front Cardiovasc Med. 2025. PMID: 40693221 Free PMC article.
-
Genotype-Phenotype Correlation in Hypertrophic Cardiomyopathy: New Variant p.Arg652Lys in MYH7.Genes (Basel). 2022 Feb 9;13(2):320. doi: 10.3390/genes13020320. Genes (Basel). 2022. PMID: 35205365 Free PMC article.
-
Troponin I - a comprehensive review of its function, structure, evolution, and role in muscle diseases.Anim Cells Syst (Seoul). 2025 Jul 28;29(1):446-468. doi: 10.1080/19768354.2025.2533821. eCollection 2025. Anim Cells Syst (Seoul). 2025. PMID: 40735528 Free PMC article. Review.
-
A mutation update for the FLNC gene in myopathies and cardiomyopathies.Hum Mutat. 2020 Jun;41(6):1091-1111. doi: 10.1002/humu.24004. Epub 2020 Mar 20. Hum Mutat. 2020. PMID: 32112656 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources